Prognostic value of postoperative albumin-bilirubin score in patients with acute type A aortic dissection after surgery: a propensity-score matched analysis Authors: Jia-Wen Hu, Tao Shi Published: 2026 ABSTRACT AbstractBackgroundPostoperative hepatic dysfunction is a frequent and severe complication in patients with acute type A aortic dissection (ATAAD) following emergency surgical repair, and it is strongly associated with adverse clinical outcomes and poor prognosis. The albumin-bilirubin (ALBI) score is an objective and well-validated indicator for evaluating hepatic function and reserve. Accumulating evidence has demonstrated its favorable prognostic value across a variety of clinical conditions, including cardiovascular diseases. Accordingly, this study was performed to comprehensively investigate the prognostic significance of the ALBI score in patients with ATAAD undergoing emergency surgical repair.MethodA total of 306 patients with ATAAD who underwent emergent repair surgery were enrolled in this single-center retrospective study. The primary outcomes of interest included delayed extubation, reintubation, neurological dysfunction, requirement for continuous renal replacement therapy (CRRT), and 30-day mortality. Propensity score matching (PSM) was performed to balance baseline characteristics between low and high postoperative ALBI (postALBI) score groups, followed by comparison of adverse outcome incidences. Multivariate logistic regression analysis was used to identify independent risk factors for poor prognosis.ResultsAfter PSM, 191 matched pairs were obtained. The high postALBI group (≥-2.12) exhibited significantly higher rates of delayed extubation (40.34% vs. 18.48%, P < 0.001), CRRT requirement (31.93% vs. 10.92%, P < 0.01), and 30-day mortality (16.81% vs. 6.72%, P = 0.017) compared to the low postALBI group (<-2.12). Although the reintubation rate was higher in the high postALBI group (18.52% vs. 9.24%), the difference approached but did not reach statistical significance (P = 0.064). Multivariate analysis revealed that high postALBI was consistently identified as a common risk factor for all adverse outcomes, including delayed extubation (OR: 2.670; 95%CI: 1.080–6.601, P = 0.033), reintubation (OR: 3.071; 95%CI: 1.076–8.769, P = 0.036), neurological dysfunction (OR: 4.174; 95%CI: 1.354–12.868, P = 0.013), CRRT requirement (OR: 4.25; 95%CI: 1.544–11.699, P = 0.005), and 30-day mortality (OR: 3.215; 95%CI: 1.132–9.127, P = 0.028). The postALBI score exhibited superior discriminatory ability over individual liver function parameters (postoperative albumin and total bilirubin) for predicting multiple adverse clinical outcomes: its AUC and 95% CI were 0.668 (0.547–0.788, P = 0.006) for 30-day mortality, 0.737 (0.645–0.829, P < 0.001) for CRRT requirement, 0.730 (0.582–0.879, P = 0.002) for neurological dysfunction, 0.706 (0.588–0.824, P = 0.001) for reintubation, and 0.637 (0.548–0.725, P = 0.003) for delayed extubation.ConclusionsThe postALBI score demonstrates independent prognostic potential for postoperative adverse events in patients with ATAAD undergoing emergent surgical repair. Owing to its simplicity and wide accessibility, this score may serve as a supportive tool for postoperative risk stratification and clinical decision-making in this high-risk population.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12872-026-06058-3.Keywords: Acute type A aortic dissection, Postoperative ALBI, Prognostic value Introduction Acute type A aortic dissection (ATAAD) is a life-threatening cardiovascular emergency characterized by rapid progression, high morbidity, and substantial mortality [1, 2]. Despite remarkable advances in surgical techniques and perioperative management, the prognosis of patients with ATAAD remains unsatisfactory. Previous studies have reported in-hospital mortality rates as high as 30%, with 1-year and 5-year post-discharge mortality ranging from 4% to 48% and 9%-63%, respectively [2]. Therefore, accurate risk stratification and early identification of high-risk patients are critical to optimize therapeutic strategies and improve clinical outcomes. Postoperative hepatic dysfunction is a frequent and severe complication in patients with ATAAD following emergency surgical repair, and it is strongly associated with adverse clinical outcomes and poor prognosis [3–5]. Emerging evidence indicates that perioperative hepatic impairment is closely linked to elevated in-hospital and 30-day mortality, as well as increased risks of multiple organ dysfunction and prolonged hospitalization, further highlighting the importance of reliable liver function assessment for risk stratification [3–5]. The albumin-bilirubin (ALBI) score, derived from serum albumin and total bilirubin, is a simple, objective, and reproducible index for evaluating liver function and reserve capacity. In contrast to traditional systems such as the Child-Pugh grade and Model for End-Stage Liver Disease (MELD) score, the ALBI score is independent of subjective clinical parameters, supporting its broad clinical utility [6]. In recent years, the prognostic value of the ALBI score has been extensively validated across a spectrum of clinical disorders, ranging from chronic liver disease to acute and chronic cardiovascular conditions [7–10]. In patients with acute heart failure, the ALBI score at discharge has been established as a useful tool for risk stratification with respect to all-cause mortality and heart failure rehospitalization [8]. Similarly, in patients undergoing transcatheter aortic valve implantation (TAVI), both in-hospital mortality and long-term mortality rates increased progressively across ALBI tertiles, and the preprocedural ALBI score exhibited a near-linear association with mortality risk [7]. A recent retrospective study further confirmed that the preoperative ALBI score was independently associated with in-hospital and long-term mortality in patients with type B aortic dissection [11]. However, the prognostic value of the ALBI score-especially the postoperative ALBI (postALBI)score-in patients with ATAAD undergoing emergent surgical repair remains unclear. Existing evidence indicates that postoperative hypoalbuminemia and hyperbilirubinemia are separately associated with amplified inflammatory responses and increased early and long-term mortality in aortic dissection patients [12, 13]. Since the ALBI score integrates both albumin and bilirubin levels, it may provide a more comprehensive evaluation of liver function and systemic status than individual biomarkers alone. Accordingly, the present study investigated the association between the postALBI score and adverse clinical outcomes in patients with ATAAD undergoing emergency surgery, and to evaluate its potential as a practical prognostic stratification tool. Materials and methods Study subjects This single-center retrospective study was conducted at the First Affiliated Hospital of Xi’an Jiaotong University. We consecutively reviewed 334 patients aged > 18 years who were admitted with a primary diagnosis of ATAAD between September 2020 and March 2022. The diagnosis of ATAAD was confirmed by computed tomographic angiography (CTA). Patients were excluded if they did not undergo surgical therapy due to aortic rupture, economic constraints, or died during surgery (n = 16), had missing clinical data (n = 7), or were lost to follow-up at 1 month postoperatively (n = 5). A total of 306 patients were ultimately included in the final analysis (Fig. 1). This study was conducted in accordance with the latest version of the Declaration of Helsinki and was approved by the Medical Science Research Ethics Committee of the First Affiliated Hospital of Xi’an Jiaotong University (Approval No.: 2022 − 578). Written informed consent was waived due to the retrospective nature of the study. Flow chart of screening Data collection Perioperative clinical data, including demographic characteristics, laboratory parameters, and surgical information, were retrospectively retrieved from electronic medical records. Postoperative parameters were all measured within 24 h after surgery. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m²). The ALBI score was computed using the formula: 0.66×log10(total bilirubin [TBil], µmol/L) – 0.085×albumin (g/L) [6]. The primary outcomes evaluated were delayed extubation (defined as mechanical ventilation duration > 48 h), reintubation, neurological dysfunction, requirement for continuous renal replacement therapy (CRRT), and 30-day mortality. Neurological dysfunction was defined as follows: (1) Acute ischemic stroke and intracerebral hemorrhage, diagnosed by postoperative neurological evaluation combined with head CT, computed tomography angiography (CTA), and/or computed tomography perfusion (CTP); (2) Clinical paraplegia confirmed by standardized neurological examination; (3) Hypoxic-ischemic encephalopathy presenting as coma, diagnosed based on neurological examination and typical cranial CT findings, including bilateral basal ganglia hypodensities, diffuse cerebral edema with effacement of cerebral sulci, loss of normal gray-white matter differentiation, and bilateral watershed hypodensities. All patients were followed up at 1 month postoperatively through outpatient re-examination or telephone consultation. Surgical procedures were performed by a single experienced surgical team under general anesthesia. Cardiopulmonary bypass (CPB) was established at various sites (right axillary artery, femoral artery, innominate artery, or double arterial cannulation) based on individual patient conditions. Patients were cooled to a nasopharyngeal temperature of 26–28 °C. The ascending aorta was clamped, and cold blood cardioplegia was infused through the coronary ostia to achieve cardiac arrest. Antegrade cerebral perfusion was established via axillary perfusion with a clamped brachiocephalic artery and direct cannulation of the left common carotid and subclavian arteries for brain protection. Detailed surgical procedures were tailored to the specific pathological changes of each patient (Table 1). Table 1Surgical types of included patients with ATAADSurgical procedureNumber of patients (%)Ascending aorta replacement + Sun’s procedure199 (65.03%)Ascending aorta replacement + Sun’s procedure + Ascending aorto-femoral artery bypass14 (4.57%)Ascending aorta replacement + Sun’s procedure + AVP14 (4.57%)Ascending aorta replacement + Sun’s procedure + Ascending aorto-femoral artery bypass + CABG3 (0.98%)Ascending aorta replacement + Sun’s procedure + endovascular stenting9 (2.94%)Ascending aorta replacement+ hemiarch replacement2 (0.65%)Bentall4 (1.31%)Bentall+ hemiarch replacement5 (1.63%)Bentall+ hemiarch replacement + MVP1 (0.33%)Bentall + CABG1 (0.33%)Bentall + MVR + TVP1 (0.33%)Bentall + Sun’s procedure36 (11.76)Bentall + Sun’s procedure + CABG3 (0.98%)Bentall + Sun’s procedure + Ascending aorto-femoral artery bypass3 (0.98%)Bentall + Sun’s procedure + endovascular stenting1(0.33%)David + Sun’s procedure5 (1.63%)David + Sun’s procedure+ CABG2 (0.65%)David + Sun’s procedure + Ascending aorto-femoral artery bypass + CABG1 (0.33%)David + Sun’s procedure+ endovascular stenting1 (0.33%)Wheat + Sun’s procedure1 (0.33%)Sun’s procedure = total arch replacement and stented elephant trunk implantation, AVP aortic valve plasty, MVP mitral valve plasty, MVR mitral valve replacement, CABG coronary artery bypass grafting, TVP tricuspid valve plasty Surgical types of included patients with ATAAD Sun’s procedure = total arch replacement and stented elephant trunk implantation, AVP aortic valve plasty, MVP mitral valve plasty, MVR mitral valve replacement, CABG coronary artery bypass grafting, TVP tricuspid valve plasty Statistical analysis Statistical analyses were performed using IBM SPSS Statistics 24.0 (IBM Corp., Chicago, IL, USA). The Kolmogorov–Smirnov test was used to assess the distribution of continuous variables. Normally distributed variables are presented as mean ± standard deviation (SD), while skewed variables are reported as median with interquartile range (IQR). Categorical variables are summarized as counts and percentages. Between-group comparisons were conducted using Student’s t-test or the Mann–Whitney U test for continuous variables, and the χ² test or Fisher’s exact test for categorical variables, as appropriate. For stratification by the postoperative ALBI score, the median value of the ALBI scores in the entire cohort was adopted as the cut-off point. Patients were accordingly divided into a low ALBI group ( < − 2.12) and a high ALBI group ( ≥ − 2.12). This grouping strategy was chosen to ensure relatively balanced sample sizes between the two subgroups, which is essential for subsequent propensity score matching (PSM) to balance baseline characteristics and maintain adequate statistical power for the analysis of multiple adverse clinical outcomes. Univariate and multivariate logistic regression analyses were performed to identify risk factors for adverse outcomes. Variables with P < 0.05 in univariate analysis, together with clinically relevant baseline characteristics, were entered into a backward stepwise multivariate model to identify independent risk factors for each outcome. To minimize potential confounding and selection bias, 1:1 propensity score matching (PSM) was performed using the nearest-neighbor matching method with a caliper width set at 0.1 times the standard deviation of the logit of the propensity score. Variables included in the propensity score model were age, gender, BMI, hypertension, and smoking history. Receiver operating characteristic (ROC) curve analysis was conducted to evaluate the predictive performance of the ALBI score for adverse clinical outcomes. Calibration was assessed using the Hosmer–Lemeshow test. All statistical tests were two-tailed, and a P-value < 0.05 was considered statistically significant. Bonferroni correction was applied to adjust for multiple comparisons, with the significance threshold maintained at P < 0.05 after correction. Sensitivity analyses based on multiple imputation for missing data are presented in the Supplemental Table. Standardized mean differences (SMD) of baseline covariates before and after PSM are visualized in the Love plot provided in the Supplemental Figure. Results Baseline characteristics The study cohort consisted of 306 ATAAD patients who underwent surgical repair, including 230 males (75.2%) and 76 females (24.8%) with a median age of 53.5 [45.3, 62.0] years. Hypertension was present in 48.4% of patients. The overall incidences of delayed extubation, reintubation, neurological dysfunction, CRRT requirement, and 30-day mortality were 33.66%, 13.40%, 9.80%, 21.24%, and 15.03%, respectively. Detailed surgical procedures and case numbers are presented in Table 1. Patients were divided into the low postALBI score group (< -2.12) and high postALBI score group (≥ -2.12) based on the median postALBI score of the entire study cohort. After PSM, 119 matched pairs were obtained. Compared to the low postALBI group, the high postALBI group had a longer surgical duration. Preoperatively, the high postALBI group exhibited higher levels of white blood cell count (WBC), blood urea nitrogen (BUN), creatinine (CRE), D-dimer (DD), and fibrin degradation product (FDP), as well as lower levels of platelet count (PLT) and albumin. Postoperatively, the high postALBI group also had lower levels of PLT, albumin, and fibrinogen (FIB), and higher levels of CRE. No significant differences were observed in other baseline characteristics between the two groups (Table 2). Table 2Baseline characteristics for patients before and after propensity matching stratified by postoperative ALBIClinical parametersUnmatched datasetMatched (1:1) datasetLow postALBI(N = 154)High postALBI (N = 152)P valueLow postALBI(N = 119)High postALBI (N = 119)P valueAge, yrs52.10 ± 12.2854.59 ± 11.140.06652.60 ± 11.7652.90 ± 11.050.838Male, n(%)109 (70.78)121 (79.61)0.07492 (77.3)92 (77.3)1.000BMI, kg/m225.83 ± 4.1125.58 ± 3.890.60625.57 ± 4.1425.54 ± 3.860.949Hypertension, %46.7550.000.57049.5849.581.000Smoking, %33.7750.00 0.004 40.3346.220.359CPB time, min153.43 ± 36.50163.63 ± 41.31 0.028 151.94 ± 36.74160.59 ± 38.800.087ACC time, min87.98 ± 22.6391.65 ± 26.310.20586.51 ± 20.9190.69 ± 25.430.180MHCA, min19.95 ± 4.6820.46 ± 5.050.40119.78 ± 4.6120.45 ± 5.380.338Blood transfusion, ml1122 ± 4461297 ± 678 0.012 1111 ± 4491248 ± 6180.063Preoperative biochemical data WBC, 10^9/L10.88 ± 3.7211.83 ± 4.770.06810.90 ± 3.8412.29 ± 4.82 0.019 Hb, g/L130.11 ± 23.27132.77 ± 22.790.339132.22 ± 23.65133.65 ± 22.720.648 PLT, 10^9/L172.45 ± 59.07144.96 ± 66.07 < 0.001 174.47 ± 56.93147.81 ± 65.63 0.002 ALT, U/L30.00[18.00, 41.00]28.00[18.00, 40.50]0.20628.00[18.00, 40.50]28.00[17.00, 41.00]0.221 AST, U/L24.00[20.00, 31.00]25.00[19.00, 50.25]0.17124.00[19.50, 32.00]25.50[19.00, 52.75]0.202 ALB, g/L36.05 ± 4.8634.60 ± 4.42 0.011 36.33 ± 4.7134.63 ± 4.54 0.008 TBIL, umol/L15.90[9.80, 24.35]17.5[14.80, 22.90]0.38416.40[12.40, 22.90]18.08[14.88, 24.30]0.521 BUN, mmol/L7.55 ± 3.968.52 ± 4.340.0547.31 ± 2.938.40 ± 4.18 0.029 CRE, umol/L74.00[58.75, 100.25]78.50[58.00, 135.50]0.07376.00[62.00, 101.5]76.00[57.75, 136.00]0.052 FIB, g/L2.81 ± 1.462.73 ± 1.490.6772.79 ± 1.402.81 ± 1.480.888 DD, mg/L7.67[2.16, 18.72]13.85[3.89, 39.45] 0.008 7.33[1.91, 17.35]14.60[5.08, 35.54] 0.002 FDP, mg/L23.03[7.89, 50.26]41.07[12.20,111.12] 0.028 21.42[6.05, 46.66]45.74[12.61, 96.14] 0.006 IL-6, pg/mL46.50[20.25, 100.25]58.96[27.26, 128.43]0.01442.80[19.59, 57.88]46.39[ 25.39, 126.90]0.030Postoperative laboratory parameters WBC, 10^9/L11.54 ± 4.0711.11 ± 3.780.34611.04 ± 3.9111.42 ± 3.720.437 Hb, g/L105.92 ± 14.43104.97 ± 14.820.581105.41 ± 14.94106.24 ± 15.000.669 PLT, 10^9/L86.47 ± 39.3871.22 ± 37.81 < 0.001 86.41 ± 37.0772.13 ± 39.47 0.004 ALT, U/L30.00[20.00, 43.00]32.00[23.00, 58.75]0.31930.00[20.00, 43.00]31.00[24.00, 59.00]0.181 AST, U/L55.00[42.25, 82.50]71.00[47.00, 145.00]0.24754.00[42.00, 83.00]70.00[48.00, 140.00]0.177 ALB, g/L40.48 ± 3.0433.55 ± 3.94 < 0.001 40.51 ± 3.0533.89 ± 3.79 < 0.001 TBIL, umol/L35.70[27.08, 51.38]42.50[32.50, 57.45]0.18837.50[28.10, 52.20]43.50[34.50, 60.80]0.195 BUN, mmol/L11.76 ± 4.8413.29 ± 5.460.01311.57 ± 4.6517.95 ± 48.850.158 CRE, umol/L111.00[86.00,145.25]142.00[102.50,207.50] 0.010 113.00[87.00,135.00]144.00[95.00, 222.00] 0.003 FIB, g/L3.11 ± 0.842.80 ± 0.91 0.004 3.06 ± 0.812.81 ± 0.88 0.029 DD, mg/L14.65[7.29, 20.36]17.82[11.88, 26.57]0.49914.84[7.30, 20.74]17.82[12.00, 26.89]0.866 FDP, mg/L47.20[23.16, 73.49]60.98[37.98, 92.91]0.16147.65[24.26, 73.76]61.51[37.53, 93.88]0.432 IL-6, pg/mL116.00[71.19, 190.40]131.70[82.59, 312.20]0.058115.00[72.15, 190.40]125.40[94.55, 307.18]0.081Bold values represent statistically significant differencesPostALBI Postoperative Albumin-bilirubin score, BMI Body mass index, CPB Cardiopulmonary bypass, ACC Aortic cross-clamp, MHCA Mild hypothermic circulatory arrest, WBC White blood cell, Hb haemoglobin, PLT Platelet, ALT Alanine aminotransferase, AST Glutamate aminotransferase, TBIL Total bilirubin, BUN Blood urea nitrogen, CRE Creatinine, FIB Fibrinogen, DD D dimer, FDP Fibrin degradation productsStatistical significance was defined as P < 0.05 Baseline characteristics for patients before and after propensity matching stratified by postoperative ALBI Bold values represent statistically significant differences PostALBI Postoperative Albumin-bilirubin score, BMI Body mass index, CPB Cardiopulmonary bypass, ACC Aortic cross-clamp, MHCA Mild hypothermic circulatory arrest, WBC White blood cell, Hb haemoglobin, PLT Platelet, ALT Alanine aminotransferase, AST Glutamate aminotransferase, TBIL Total bilirubin, BUN Blood urea nitrogen, CRE Creatinine, FIB Fibrinogen, DD D dimer, FDP Fibrin degradation products Statistical significance was defined as P < 0.05 Comparison of adverse clinical events between two groups As shown in Table 3; Fig. 2, after PSM, the high postALBI group had a significantly higher delayed extubation rate compared to the low postALBI group (40.34% vs. 18.48%, P < 0.001). Although the reintubation rate was higher in the high postALBI group (18.52% vs. 9.24%), the difference did not reach statistical significance (P = 0.064). The incidence of neurological dysfunction was 13.44% in the high postALBI group and 6.72% in the low postALBI group, with no significant between-group difference. The CRRT requirement rate (31.93% vs. 10.92%, P < 0.01) and 30-day mortality rate (16.81% vs. 6.72%, P = 0.017) were significantly higher in the high postALBI group. Table 3Postoperative characteristics of the two groupsClinical parametersUnmatched datasetMatched (1:1) datasetLow postALBI(N = 154)High postALBI (N = 152)P valueLow postALBI(N = 119)High postALBI (N = 119)P valueDelayed extubation, %24.0343.42 < 0.001 18.4840.34 < 0.001 Reintubation, %9.0917.76 0.038 9.2418.520.064Neurological dysfunction, %7.7911.840.2346.7213.440.085CRRT, %13.6328.95 < 0.001 10.9231.93 < 0.001 30d mortality, %9.0921.05 0.003 6.7216.81 0.017 Bold values represent statistically significant differencesPostALBI Postoperative Albumin-bilirubin score, CRRT Continuous renal replacement therapyStatistical significance was defined as P < 0.05 Postoperative characteristics of the two groups Bold values represent statistically significant differences PostALBI Postoperative Albumin-bilirubin score, CRRT Continuous renal replacement therapy Statistical significance was defined as P < 0.05 K-M curves of 30d mortality before and after PSM Univariate and multivariate logistic regression analysis Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for adverse clinical outcomes in the PSM cohort (Table 4). For delayed extubation, both preALBI (OR: 3.338; 95%CI: 1.317–8.455, P = 0.011) and postALBI (OR: 2.670; 95%CI: 1.080–6.601, P = 0.033) were independent predictive factors. Risk factors for reintubation included low preoperative hematocrit (preHCT) (OR: 0.918; 95%CI: 0.846–0.996, P = 0.040), low postoperative FIB (postFIB) (OR: 0.407; 95%CI: 0.190–0.869, P = 0.020), and high postALBI (OR: 3.071; 95%CI: 1.076–8.769, P = 0.036). Longer CPB time (OR: 1.020; 95%CI: 1.010–1.031, P < 0.01) and high postALBI (OR: 4.174; 95%CI: 1.354–12.868, P = 0.013) were independent predictors of neurological dysfunction. For CRRT requirement, high preoperative WBC (preWBC) (OR: 1.616; 95%CI: 1.049–1.285, P = 0.004), low postoperative PLT (postPLT) (OR: 0.969; 95%CI: 0.950–0.988, P = 0.002), and high postALBI (OR: 4.25; 95%CI: 1.544–11.699, P = 0.005) were significant risk factors. Low postFIB (OR: 0.317; 95%CI: 0.163–0.615, P < 0.001) and high postALBI (OR: 3.215; 95%CI: 1.132–9.127, P = 0.028) were independently associated with 30-day mortality. Notably, high postALBI was a common risk factor for all adverse outcomes evaluated in this study. Table 4Univariate and multivariate regression analysis for poor clinical outcomesClinical parametersUnmatched datasetMatched (1:1) datasetUnivariate analysisP valueMultivariate analysisP valueUnivariate analysisP valueMultivariate analysisP valueDelayed extubation CPB1.015[1.007,1.024] < 0.001 1.014[1.005,1.024] 0.003 1.013[1.004,1.021] 0.003 Length of surgery1.347[1.113,1.630] 0.002 1.356[1.112,1.653] 0.003 preWBC1.150[1.046,1.264] 0.004 preALBI2.492[1.178,5.274] 0.017 2.296[1.013,5.204] 0.047 2.897[1.275,6.584] 0.011 3.338[1.317,8.455] 0.011 postALBI2.136[1.029,4.434] 0.042 2.808[1.251,6.302] 0.012 2.670[1.080,6.601] 0.033 Reintubation age1.052[1.014,1.092] 0.007 1.046[1.001,1.092] 0.045 1.038[1.004,1.074] 0.029 CPB1.012[1.002,1.022] 0.018 Length of surgery1.441[1.142,1.819] 0.002 preHCT0.942[0.890,0.998] 0.044 0.918[0.846,0.996] 0.040 postPLT0.983[0.968,0.999] 0.035 0.978[0.964,0.992] 0.003 postFIB0.341[0.178,0.655] 0.001 0.413[0.204,0.834] 0.014 0.317[0.169,0.596] < 0.001 0.407[0.190,0.869] 0.020 postALBI9.588[2.812,32.693] < 0.001 8.197[2.317,29.000] 0.001 3.806[1.401,10.334] 0.009 3.071[1.076,8.769] 0.036 Neurological dysfunction CPB1.017[1.008,1.025] < 0.001 1.022[1.011,1.032] < 0.001 1.020[1.010,1.031] < 0.001 Length of surgery1.498[1.203,1.864] < 0.001 1.387[1.029,1.871] 0.032 1.719[1.305,2.265] < 0.001 prePLT0.991[0.982,0.999] 0.027 0.989[0.979,0.999] 0.035 postPLT0.978[0.964,0.991] 0.001 0.974[0.958,0.989] 0.001 postALBI2.785[1.137,6.818] 0.025 5.276[1.820,15.296] 0.002 4.174[1.354,12.868] 0.013 CRRT Length of surgery1.472[1.190,1.821] < 0.001 prePLT0.989[0.982,0.996] 0.003 0.983[0.975,0.990] < 0.001 preWBC1.161[1.062,1.270] 0.001 1.137[1.033,1.252] 0.009 1.191[1.093,1.297] < 0.001 1.161[1.049,1.285] 0.004 postPLT0.979[0.968,0.991] < 0.001 0.964[0.951,0.977] < 0.001 0.969[0.950,0.988] 0.002 postFIB0.457[0.289,0.723] < 0.001 0.502[0.293,0.862] 0.012 0.368[0.226,0.597] < 0.001 postALBI6.108[2.497,14.94] < 0.001 4.369[1.566,12.189] 0.005 7.829[3.261,18,792] < 0.001 4.250[1.544,11.699] 0.005 30-day mortality CPB1.011[1.004,1.019] 0.004 Length of surgery1.579[1.304,1.913] < 0.001 1.313[1.001,1.722] 0.049 1.416[1.122,1.786] 0.003 postWBC1.120[1.027,1.220] 0.010 1.123[1.022,1.235] 0.016 1.107[1.003,1.222] 0.043 postFIB0.274[0.141,0.531] < 0.001 0.317[0.163,0.615] < 0.001 postALBI4.080[1.755,9.484] 0.001 3.760[1.482,9.538] 0.005 4.443[1.644,12.008] 0.003 3.215[1.132,9.127] 0.028 Bold values represent statistically significant differencesPre preoperative, Post postoperative, CPB Cardiopulmonary bypass, CRRT continuous renal replacement therapy, WBC White blood cell, ALBI Albumin-bilirubin score, HCT Hematocrit, PLT Platelet, FIB FibrinogenStatistical significance was defined as P < 0.05 Univariate and multivariate regression analysis for poor clinical outcomes Bold values represent statistically significant differences Pre preoperative, Post postoperative, CPB Cardiopulmonary bypass, CRRT continuous renal replacement therapy, WBC White blood cell, ALBI Albumin-bilirubin score, HCT Hematocrit, PLT Platelet, FIB Fibrinogen Statistical significance was defined as P < 0.05 Comparison of postALBI, postALB, and postTBIL in predicting adverse prognosis ROC curve analysis was performed to assess the predictive value of postALBI, postoperative albumin (postALB), and postoperative total bilirubin (postTBIL) for postoperative adverse outcomes (Table 5; Fig. 3). For 30-day mortality, the AUC of postALBI was 0.668 (95% CI: 0.547–0.788, P = 0.006), which was higher than postALB (AUC = 0.651, 95% CI: 0.528–0.773, P = 0.016). PostALBI also showed superior predictive performance for CRRT requirement (AUC = 0.737, 95% CI: 0.645–0.829, P < 0.001), neurological dysfunction (AUC = 0.730, 95% CI: 0.582–0.879, P = 0.002), reintubation (AUC = 0.706, 95% CI: 0.588–0.824, P = 0.001), and delayed extubation (AUC = 0.637, 95% CI: 0.548–0.725, P = 0.003) compared with postALB and postTBIL. Overall, postALBI exhibited a better discriminatory capacity than individual liver function parameters in predicting adverse clinical outcomes. Table 5Comparison of postALBI, postALB, and postTBIL in predicting adverse prognosisOutcomes and VariablesAUC (95% CI)P valueSensitivity,%Sepcificity,%30-day mortality postALBI0.668 (0.547–0.788) 0.006 67.962.1 postALB0.651 (0.528–0.773) 0.016 67.960.7CRRT postALBI0.737 (0.645–0.829) < 0.001 74.565.6 postALB0.729 (0.633–0.824) < 0.001 66.767.2Neurological dysfunction postALBI0.730 (0.582–0.879) 0.002 81.359.1 postALB0.698 (0.538–0.858) 0.015 50.086.4Reintubation postALBI0.706 (0.588–0.824) 0.001 61.375.4 postTBIL0.649 (0.536–0.763) 0.010 80.644.6 postALB0.655 (0.530–0.780) 0.015 64.563.1Delayed extubation postALBI0.637 (0.548–0.725) 0.003 67.263.1 postALB0.607 (0.518–0.697) 0.019 63.857.4Bold values represent statistically significant differencespostALBI postoperative Albumin-bilirubin score, postALB postoperative albumin, postTBIL postoperative total bilirubin, AUC area under the curve, CI confidence interval, CRRT continuous renal replacement therapyStatistical significance was defined as P < 0.05 Comparison of postALBI, postALB, and postTBIL in predicting adverse prognosis Bold values represent statistically significant differences postALBI postoperative Albumin-bilirubin score, postALB postoperative albumin, postTBIL postoperative total bilirubin, AUC area under the curve, CI confidence interval, CRRT continuous renal replacement therapy Statistical significance was defined as P < 0.05 Receiver operating characteristic curves of postoperative ALBI, ALB, and TBIL in predicting adverse clinical outcomes Discussion This study comprehensively evaluated the prognostic value of the postALBI score in ATAAD patients undergoing emergent surgical repair. The key finding was that an elevated postALBI score served as an independent predictor of multiple adverse clinical outcomes, including delayed extubation, reintubation, requirement for CRRT, neurological dysfunction, and 30-day mortality. Furthermore, the postALBI score exhibited better or at least equivalent predictive performance for short-term adverse outcomes compared with postALB and postTBIL alone. These results highlight the potential of the postALBI score as a valuable tool for risk stratification and prognostic assessment in this high-risk patient population. The overall incidences of CRRT requirement (21.24%), neurological dysfunction (9.80%), and 30-day mortality (15.03%) in our study are consistent with those reported in previous multicenter studies (15%-22%, 10%-17%, and 14%-22%, respectively), indicating the generalizability of our findings [3, 4, 14]. The ALBI score, originally developed for assessing liver function and long-term prognosis in patients with liver diseases and cancer [6], has recently been shown to have prognostic value in various cardiovascular diseases, such as valvular heart disease, heart failure, cardiomyopathy, atrial septal defect, and type B aortic dissection [5, 9, 11, 15, 16]. However, this is the first study to systematically investigate the association between the postALBI score and postoperative outcomes in ATAAD patients. The underlying mechanisms linking high postALBI to adverse outcomes in ATAAD patients are complex and may involve multiple pathways. First, the onset of aortic dissection triggers a profound systemic inflammatory response, which is further amplified by cardiopulmonary bypass (CPB) and aortic cross-clamping during surgery. Such excessive inflammation increases capillary permeability, leading to albumin extravasation and subsequent hypoalbuminemia [17]. Serum albumin exerts critical anti-inflammatory, antioxidant, and free-radical scavenging functions, with approximately three-quarters of serum free-radical trapping activity attributed to albumin [18]. Hypoalbuminemia is associated with sustained inflammation, dysregulated coagulation and fibrinolysis, impaired immune function, and increased vulnerability to infections and thrombotic events, all of which contribute to unfavorable clinical outcomes [19–21]. Second, hyperbilirubinemia, another key component of the ALBI score, is mainly induced by CPB-related hypoperfusion, exaggerated inflammation, and hemolysis [12, 22]. Although unconjugated bilirubin possesses intrinsic anti-inflammatory and antioxidant properties, postoperative hyperbilirubinemia generally reflects the severity of systemic inflammation and oxidative stress [22]. A meta-analysis indicated that postoperative hyperbilirubinemia is associated with prolonged ICU and hospital stays, increased requirements for invasive ventilation and new-onset dialysis, and higher mortality in patients undergoing cardiac surgery with CPB [23]. Additionally, perioperative hypoxia is common in ATAAD patients, with preoperative and postoperative hypoxia rates of 46.5% and 67.6%, respectively [12, 24]. Hypoxia-induced hepatocellular injury impairs bilirubin uptake and excretion, further increasing serum bilirubin levels [25]. Collectively, these disturbances contribute to an elevated postoperative ALBI score and its association with adverse clinical outcomes. The findings of the present study have notable clinical implications. The ALBI score is a simple, objective, and readily accessible metric derived from routine serum albumin and total bilirubin laboratory tests, which enables convenient clinical application. Stratification of patients at high postoperative risk based on the postALBI score may assist clinicians in formulating individualized perioperative management strategies. These strategies include optimized fluid resuscitation, targeted anti-inflammatory treatment, nutritional intervention to improve albumin status, and enhanced multi-organ function monitoring, which may contribute to improved postoperative outcomes in ATAAD patients. Furthermore, the postALBI score has the potential to serve as a practical surrogate endpoint for future clinical trials evaluating novel therapeutic strategies for this high-risk patient cohort. Several limitations of this study should be acknowledged. First, this was a single-center retrospective study, which may carry inherent selection bias and limit the external generalizability of the results. Although PSM was applied to balance baseline characteristics, residual confounding cannot be entirely excluded. Second, the relatively small sample size may reduce the statistical power of certain analyses. Third, the precise mechanisms linking the postoperative ALBI score to adverse outcomes were not directly explored, and further experimental and clinical studies are needed to clarify these pathways. Finally, the optimal cutoff value of the ALBI score for risk stratification in ATAAD patients requires validation in large-scale multicenter studies. In conclusion, the postALBI score represents a reliable, convenient, and independent prognostic marker for multiple adverse clinical outcomes in ATAAD patients undergoing emergency surgical repair. Routine implementation of this score in clinical practice may facilitate risk stratification, guide therapeutic decision-making, and improve perioperative management. Large-scale multicenter prospective studies are warranted to validate these findings and further define the clinical role of the ALBI score in this high-risk population. Supplementary Information Supplementary Material 1. Supplementary Material 2. Supplementary Material 3. Acknowledgements Not applicable. Clinical trial number Not applicable. Authors' contributions Jiawen Hu and Tao Shi developed the research hypothesis, designed the study protocol, and determined the primary and secondary outcomes. Jiawen Hu retrieved and verified perioperative clinical data, laboratory parameters, and surgical information from the hospital’s electronic medical record system, and completed patient follow-up. Jiawen Hu performed propensity score matching (PSM), univariate and multivariate logistic regression analyses, and interpreted the statistical results using IBM SPSS Statistics 24.0. Jiawen Hu wrote the initial draft of the manuscript, including the Abstract, Introduction, Materials and Methods, Results, and Discussion sections. Tao Shi revised the manuscript for important intellectual content, including refining the discussion of mechanisms, modifying statistical descriptions, and optimizing the structure of the text. Funding Not applicable. Data availability The raw data supporting the conclusions of this article will be made available by the authors on request. Declarations Ethics approval and consent to participate This study was conducted in accordance with the latest version of the Declaration of Helsinki and was approved by the Medical Science Research Ethics Committee of the First Affiliated Hospital of Xi’an Jiaotong University (Approval No.: 2022 − 578). Written informed consent was waived due to the retrospective nature of the study. Consent for publication All authors have read and approved the final manuscript, and confirm their consent for the publication of this work. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The raw data supporting the conclusions of this article will be made available by the authors on request.